Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma

Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma

Abstract Background T cell receptor (TCR)-T cells possess similar effector function, but milder and more durable signal activation compared with chimeric antigen receptor-T cells. TCR-T cell therapy is another active field of cellular immunotherapy for cancer. Methods We previously developed a human...

Full description

Bibliographic Details
Main Authors: Chenggong Li, Fen Zhou, Jing Wang, Qi Chang, Mengyi Du, Wenjing Luo, Yinqiang Zhang, Jia Xu, Lu Tang, Huiwen Jiang, Lin Liu, Haiming Kou, Cong Lu, Danying Liao, Jianghua Wu, Qiuzhe Wei, Sha Ke, Jun Deng, Cheng Liu, Heng Mei, Yu Hu
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Journal of Hematology & Oncology
Subjects:
γ/δ TCR-T cells
DLBCL
Primary CNS lymphoma
Relapsed or refractory
Cellular immunotherapy
Online Access:https://doi.org/10.1186/s13045-023-01402-y

Internet

https://doi.org/10.1186/s13045-023-01402-y

Similar Items